Formosa Laboratories, Inc.

Taiwan Stock Exchange 4746.TW

Formosa Laboratories, Inc. Free Cash Flow Yield on January 14, 2025: 3.54%

Formosa Laboratories, Inc. Free Cash Flow Yield is 3.54% on January 14, 2025, a 55.92% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Formosa Laboratories, Inc. 52-week high Free Cash Flow Yield is 3.69% on December 27, 2024, which is 4.06% above the current Free Cash Flow Yield.
Formosa Laboratories, Inc. 52-week low Free Cash Flow Yield is 2.03% on January 26, 2024, which is -42.75% below the current Free Cash Flow Yield.
Formosa Laboratories, Inc. average Free Cash Flow Yield for the last 52 weeks is 2.63%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Taiwan Stock Exchange: 4746.TW

Formosa Laboratories, Inc.

CEO	Dr. Chen-Yu Cheng Ph.D.
IPO Date	Feb. 28, 2011
Location	Taiwan
Headquarters	36 Hoping Street
Employees	867
Sector	Health Care
Industries Pharmaceuticals

Description

Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.

Key trends

Past 5 years